Explain Quality by Design (QbD) principles for biologics development.

Quality by Design (QbD) systematically builds quality into biologics development per ICH Q8-Q12: 1) Target Product Profile (TPP) - define clinical and quality requirements for intended use. 2) Critical Quality Attributes (CQAs) - identify quality attributes impacting safety/efficacy (potency, purity, aggregates, glycosylation, charge variants). 3) Critical Process Parameters (CPPs) - process variables affecting CQAs (pH, temperature, DO, feed rates). 4) Design Space - multidimensional combination of inputs and process parameters providing acceptable quality; operating within design space is not a regulatory change. 5) Control Strategy - planned controls based on process understanding (in-process, PAT, real-time release). 6) Risk Assessment - FMEA, cause-and-effect diagrams to prioritize parameters. 7) Lifecycle Management - continuous improvement within design space. Implementation: DoE for process characterization, multivariate analysis, mechanistic modeling. Benefits: reduced batch failures, increased process understanding, regulatory flexibility, enhanced continuous improvement.